NEXGEL (NASDAQ:NXGL) Advisory Board Member Dr. Leonard Nelson joins Natalie Stoberman from the Proactive studio to share the upcoming launch of its new proprietary hydrogel eye patch to treat amblyopia, a type of poor vision that typically occurs in one eye but can occur in both eyes.
NEXGEL is a leading provider of ultra-gentle, high-water-content hydrogels for healthcare and consumer applications. Alongside its strategic partners, NEXGEL has formulated more than 200 different combinations to bring natural ingredients to gentle skin patches that can be worn for long periods of time with little to no irritation.